(Q22000875)

English

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

scientific article

In more languages

Statements

scholarly article

0 references

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Paul P Tak

author given names

Paul P

author last names

Tak

1 reference

6 February 2023

author name string

Amber Y Goedkoop

1

author given names

Amber Y

author last names

Goedkoop

1 reference

6 February 2023

Maarten C Kraan

2

author given names

Maarten C

author last names

Kraan

1 reference

6 February 2023

Daisy I Picavet

3

author given names

Daisy I

author last names

Picavet

1 reference

6 February 2023

Menno A de Rie

4

author given names

Menno A

author last names

de Rie

1 reference

6 February 2023

Marcel B M Teunissen

5

author given names

Marcel B M

author last names

Teunissen

1 reference

6 February 2023

Jan D Bos

6

author given names

Jan D

author last names

Bos

1 reference

6 February 2023

language of work or name

0 references

publication date

2004

0 references

Arthritis Research and Therapy

0 references

6

0 references

4

0 references

R326-34

0 references

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

19 March 2017

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

19 March 2017

Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

19 March 2017

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

7 April 2017

Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Quantification of the cell infiltrate in synovial tissue by digital image analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

12 September 2017

Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

27 September 2017

Leukocyte-endothelial adhesion molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

27 September 2017

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

30 May 2018

Role of the microcirculation in the treatment and pathogenesis of psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

30 May 2018

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

30 May 2018

Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464872

29 November 2018

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructure of the capillary loops in the dermal papillae of psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of patient outcome in arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous leukocyte trafficking and psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular changes in psoriatic knee joint synovitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recalcitrant psoriatic arthritis with anti-tumor necrosis factor-alpha antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis--an immunohistochemical and mRNA analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

0 references

0 references

ResearchGate publication ID

0 references

Springer Nature article ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22000875&oldid=1959838823"